Screener
Vir Biotechnology, Inc. VIR Business Segments — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Segment revenue | $238,946 | $1,214 | $238,917 | $4,246 |
| Less: Segment expenses (1) | ||||
| Cost of revenue | — | 11 | — | 11 |
| Research and development | ||||
| Contract manufacturing | 23,967 | 14,063 | 59,974 | 23,399 |
| Personnel (2) | 28,512 | 33,165 | 60,040 | 66,883 |
| Clinical costs | 22,532 | 20,361 | 48,666 | 40,967 |
| Licenses, collaborations and contingent consideration, net | 41,211 | 11,301 | 38,402 | 47,892 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s business segments — total revenues?
- Vir Biotechnology, Inc. (VIR) reported business segments — total revenues of $238.95M in Q2 2026.
- How has Vir Biotechnology, Inc.'s business segments — total revenues changed year-over-year?
- Vir Biotechnology, Inc.'s business segments — total revenues increased by 19582.5% year-over-year, from $1.21M to $238.95M.
- What is the long-term trend for Vir Biotechnology, Inc.'s business segments — total revenues?
- Over 2 years (2022 to 2025), Vir Biotechnology, Inc.'s business segments — total revenues has grown at a -79.4% compound annual growth rate (CAGR), from $1.62B to $68.56M.
- What does business segments — total revenues mean?
- Represents the total gross income generated by the primary business segment through its core operations, including product sales, royalties, and collaboration revenue. This metric serves as a key indicator of the segment's market traction and its ability to monetize its technology platforms.
Ask your AI about Vir Biotechnology, Inc.'s business segments — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude